Amyloid-β oligomers are sequestered by both intracellular and extracellular chaperones

Biochemistry

Volumn 51, Issue 46, 2012, Pages 9270-9276

  Narayan, Priyanka ^a   Meehan, Sarah ^a   Carver, John A ^b   Wilson, Mark R ^c   Dobson, Christopher M ^a   Klenerman, David ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF ADELAIDE   (Australia)

^c UNIVERSITY OF WOLLONGONG   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME ACTIVITY; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; PEPTIDES;

ALZHEIMERS DISEASE; AMYLOID-BETA PEPTIDES; EXTRACELLULAR ENVIRONMENTS; FIBRILLAR STRUCTURES; HETEROGENEOUS ENSEMBLES; MECHANISM OF ACTION; MOLECULAR CHAPERONES; SINGLE MOLECULE FLUORESCENCE TECHNIQUES;

OLIGOMERS;

ALPHA CRYSTALLIN; AMYLOID BETA PROTEIN[1-40];

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; EXTRACELLULAR SPACE; FLUORESCENCE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN INTERACTION; UPREGULATION;

EID: 84869392249     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi301277k     Document Type: Article

References (37)

1. Chiti, F. and Dobson, C. M. (2006) Protein misfolding, functional amyloid, and human disease Annu. Rev. Biochem. 75, 333-366 (Pubitemid 44118036)
2. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., and Ashe, K. H. (2005) Natural oligomers of the amyloid-β protein specifically disrupt cognitive function Nat. Neurosci. 8, 79-84 (Pubitemid 41236735)
3. Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J. S., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases Nature 416, 507-511 (Pubitemid 34288846)
4. Orte, A., Birkett, N. R., Clarke, R. W., Devlin, G. L., Dobson, C. M., and Klenerman, D. (2008) Direct characterization of amyloidogenic oligomers by single-molecule fluorescence Proc. Natl. Acad. Sci. U.S.A. 105, 14424-14429
5. Narayan, P., Orte, A., Clarke, R. W., Bolognesi, B., Hook, S., Ganzinger, K. A., Meehan, S., Wilson, M. R., Dobson, C. M., and Klenerman, D. (2012) The extracellular chaperone clusterin sequesters oligomeric forms of the amyloid-β1-40 peptide Nat. Struct. Mol. Biol. 19, 79-83
6. Cremades, N., Cohen, S. I., Deas, E., Abramov, A. Y., Chen, A. Y., Orte, A., Sandal, M., Clarke, R. W., Dunne, P., Aprile, F. A., Bertoncini, C. W., Wood, N. W., Knowles, T. P., Dobson, C. M., and Klenerman, D. (2012) Direct observation of the interconversion of normal and toxic forms of α-synuclein Cell 149, 1048-1059
7. Hartl, F. U., Bracher, A., and Hayer-Hartl, M. (2011) Molecular chaperones in protein folding and proteostasis Nature 475, 324-332
8. Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., Jones, N., Thomas, C., Stretton, A., Morgan, A. R., Lovestone, S., Powell, J., Proitsi, P., Lupton, M. K., Brayne, C., Rubinsztein, D. C., Gill, M., Lawlor, B., Lynch, A., Morgan, K., Brown, K. S., Passmore, P. A., Craig, D., McGuinness, B., Todd, S., Holmes, C., Mann, D., Smith, A. D., Love, S., Kehoe, P. G., Hardy, J., Mead, S., Fox, N., Rossor, M., Collinge, J., Maier, W., Jessen, F., Schurmann, B., van den Bussche, H., Heuser, I., Kornhuber, J., Wiltfang, J., Dichgans, M., Frolich, L., Hampel, H., Hull, M., Rujescu, D., Goate, A. M., Kauwe, J. S. K., Cruchaga, C., Nowotny, P., Morris, J. C., Mayo, K., Sleegers, K., Bettens, K., Engelborghs, S., De Deyn, P. P., Van Broeckhoven, C., Livingston, G., Bass, N. J., Gurling, H., McQuillin, A., Gwilliam, R., Deloukas, P., Al-Chalabi, A., Shaw, C. E., Tsolaki, M., Singleton, A. B., Guerreiro, R., Muhleisen, T. W., Nothen, M. M., Moebus, S., Jockel, K.-H., Klopp, N., Wichmann, H. E., Carrasquillo, M. M., Pankratz, V. S., Younkin, S. G., Holmans, P. A., ODonovan, M., Owen, M. J., and Williams, J. (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimers disease Nat. Genet. 41, 1088-1093
9. Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., Tavernier, B., Letenneur, L., Bettens, K., Berr, C., Pasquier, F., Fievet, N., Barberger-Gateau, P., Engelborghs, S., De Deyn, P., Mateo, I., Franck, A., Helisalmi, S., Porcellini, E., Hanon, O., de Pancorbo, M. M., Lendon, C., Dufouil, C., Jaillard, C., Leveillard, T., Alvarez, V., Bosco, P., Mancuso, M., Panza, F., Nacmias, B., Bossu, P., Piccardi, P., Annoni, G., Seripa, D., Galimberti, D., Hannequin, D., Licastro, F., Soininen, H., Ritchie, K., Blanche, H., Dartigues, J.-F., Tzourio, C., Gut, I., Van Broeckhoven, C., Alperovitch, A., Lathrop, M., and Amouyel, P. (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimers disease Nat. Genet. 41, 1094-1099
10. Carver, J. A., Rekas, A., Thorn, D. C., and Wilson, M. R. (2003) Small heat-shock proteins and clusterin: Intra-and extracellular molecular chaperones with a common mechanism of action and function? IUBMB Life 55, 661-668 (Pubitemid 38116418)
11. Shinohara, H., Inaguma, Y., Goto, S., Inagaki, T., and Kato, K. (1993) αB Crystallin and HSP28 are enhanced in the cerebral cortex of patients with Alzheimers disease J. Neurol. Sci. 119, 203-208
12. Renkawek, K., Voorter, C., Bosman, G., van Workum, F., and de Jong, W. (1994) Expression of αB-crystallin in Alzheimers disease Acta Neuropathol. 87, 155-160
13. Calero, M., Rostagno, A., Matsubara, E., Zlokovic, B., Frangione, B., and Ghiso, J. (2000) Apolipoprotein J (clusterin) and Alzheimers disease Microsc. Res. Tech. 50, 305-315
14. Lidström, A. M., Bogdanovic, N., Hesse, C., Volkman, I., Davidsson, P., and Blennow, K. (1998) Clusterin (Apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimers disease Exp. Neurol. 154, 511-521 (Pubitemid 29044220)
15. Bayer, T. A. and Wirths, O. (2010) Intracellular accumulation of amyloid-β: A predictor for synaptic dysfunction and neuron loss in Alzheimers disease Front. Aging Neurosci. 2, 8
16. Friedrich, R. P., Tepper, K., Rönicke, R., Soom, M., Westermann, M., Reymann, K., Kaether, C., and Fändrich, M. (2010) Mechanism of amyloid plaque formation suggests an intracellular basis of Aβ pathogenicity Proc. Natl. Acad. Sci. U.S.A. 107, 1942-1947
17. Shammas, S. L., Waudby, C. A., Wang, S., Buell, A. K., Knowles, T. P., Ecroyd, H., Welland, M. E., Carver, J. A., Dobson, C. M., and Meehan, S. (2011) Binding of the molecular chaperone αB-crystallin to Aβ amyloid fibrils inhibits fibril elongation Biophys. J. 101, 1681-1689
18. Mannini, B., Cascella, R., Zampagni, M., van Waarde-Verhagen, M., Meehan, S., Roodveldt, C., Campioni, S., Boninsegna, M., Penco, A., Relini, A., Kampinga, H. H., Dobson, C. M., Wilson, M. R., Cecchi, C., and Chiti, F. (2012) Molecular mechanisms used by chaperones to reduce the toxicity of aberrant protein oligomers Proc. Natl. Acad. Sci. U.S.A. 109, 12479-12484
19. Mehta, P. D., Pirttila, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., and Wisniewski, H. M. (2000) Plasma and cerebrospinal fluid levels of amyloid-β proteins 1-40 and 1-42 in Alzheimer disease Arch. Neurol. 57, 100-105 (Pubitemid 30027637)
20. Wilson, M. R., Yerbury, J. J., and Poon, S. (2008) Extracellular chaperones and amyloids. In Heat Shock Proteins and the Brain: Implications for Neurodegenerative Diseases and Neuroprotection (Asea, A. A. A. and Brown, I. R., Eds.) pp 283-315, Springer, Dordrecht, The Netherlands.
21. Bloemendal, H., de Jong, W., Jaenicke, R., Lubsen, N. H., Slingsby, C., and Tardieu, A. (2004) Ageing and vision: Structure, stability and function of lens crystallins Prog. Biophys. Mol. Biol. 86, 407-485 (Pubitemid 39081525)
22. de Jong, W. W., Caspers, G.-J., and Leunissen, J. A. M. (1998) Genealogy of the α-crystallin-small heat-shock protein superfamily Int. J. Biol. Macromol. 22, 151-162 (Pubitemid 28276729)
23. Kudva, Y. C., Hiddinga, H. J., Butler, P. C., Mueske, C. S., and Eberhardt, N. L. (1997) Small heat shock proteins inhibit in vitro Aβ1-42 amyloidogenesis FEBS Lett. 416, 117-121 (Pubitemid 27470814)
24. Kumita, J. R., Poon, S., Caddy, G. L., Hagan, C. L., Dumoulin, M., Yerbury, J. J., Stewart, E. M., Robinson, C. V., Wilson, M. R., and Dobson, C. M. (2007) The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species J. Mol. Biol. 369, 157-167 (Pubitemid 46635433)
25. Yerbury, J. J., Poon, S., Meehan, S., Thompson, B., Kumita, J. R., Dobson, C. M., and Wilson, M. R. (2007) The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures FASEB J. 21, 2312-2322 (Pubitemid 47230661)
26. Sánchez, L., Madurga, S., Pukala, T., Vilaseca, M., López-Iglesias, C., Robinson, C. V., Giralt, E., and Carulla, N. (2011) Aβ40 and Aβ42 amyloid fibrils exhibit distinct molecular recycling properties J. Am. Chem. Soc. 133, 6505-6508
27. Cheon, M., Chang, I., Mohanty, S., Luheshi, L. M., Dobson, C. M., Vendruscolo, M., and Favrin, G. (2007) Structural reorganisation and potential toxicity of oligomeric species formed during the assembly of amyloid fibrils PLoS Comput. Biol. 3, 1727-1738 (Pubitemid 47502977)
28. Lee, J., Culyba, E. K., Powers, E. T., and Kelly, J. W. (2011) Amyloid-β forms fibrils by nucleated conformational conversion of oligomers Nat. Chem. Biol. 7, 602-609
29. Treweek, T. M., Ecroyd, H., Williams, D. M., Meehan, S., Carver, J. A., and Walker, M. J. (2007) Site-directed mutations in the C-terminal extension of human αB-crystallin affect chaperone function and block amyloid fibril formation PLoS One 2, e1046
30. Lührs, T., Ritter, C., Adrian, M., Riek-Loher, D., Bohrmann, B., Döbeli, H., Schubert, D., and Riek, R. (2005) 3D structure of Alzheimers amyloid-β(1-42) fibrils Proc. Natl. Acad. Sci. U.S.A. 102, 17342-17347
31. Ladiwala, A. R. A., Litt, J., Kane, R. S., Aucoin, D. S., Smith, S. O., Ranjan, S., Davis, J., VanNostrand, W. E., and Tessier, P. M. (2012) Conformational differences between two amyloid β oligomers of similar size and dissimilar toxicity J. Biol. Chem. 287, 24765-24773
32. Bolognesi, B., Kumita, J. R., Barros, T. P., Esbjorner, E. K., Luheshi, L. M., Crowther, D. C., Wilson, M. R., Dobson, C. M., Favrin, G., and Yerbury, J. J. (2010) ANS binding reveals common features of cytotoxic amyloid species ACS Chem. Biol. 5, 735-740
33. Humphreys, D. T. (1999) Clusterin has chaperone-like activity similar to that of small heat shock proteins J. Biol. Chem. 274, 6875
34. Wyatt, A., Yerbury, J., Berghofer, P., Greguric, I., Katsifis, A., Dobson, C., and Wilson, M. (2011) Clusterin facilitates in vivo clearance of extracellular misfolded proteins Cell. Mol. Life Sci. 68, 3919-3931
35. Dehle, F., Ecroyd, H., Musgrave, I., and Carver, J. (2010) αB-Crystallin inhibits the cell toxicity associated with amyloid fibril formation by κ-casein and the amyloid-β peptide Cell Stress Chaperones 15, 1013-1026
36. Dobson, C. M. (2003) Protein folding and misfolding Nature 426, 884-890 (Pubitemid 38056880)
37. Dobson, C. M. (1999) Protein misfolding, evolution and disease Trends Biochem. Sci. 24, 329-332 (Pubitemid 29421804)